Latest Breaking News On - Deputy executive director noel wathion - Page 1 : comparemela.com

Full article EMA s Deputy Executive Director Noel Wathion said “they have not even filed an application with us yet”, in an interview with Belgian newspaper Het Nieuwsblad The European Medicines Authority (EMA) will most likely not be able to approve the COVID-19 vaccine developed by drug maker AstraZeneca and the University of Oxford in January, the watchdog’s Deputy Executive Director Noel Wathion said. “They have not even filed an application with us yet”, Wathion said in an interview with Belgian newspaper Het Nieuwsblad published on Tuesday. European regulators have only received some information about the vaccine, Wathion said. “Not even enough to warrant a conditional marketing license”, he said. “We need additional data about the quality of the vaccine. And after that, the company has to formally apply.”

United kingdomMatt hancockNoel wathionEuropean medicines authorityUniversity of oxfordExecutive director noel wathionHet nieuwsbladDeputy executive director noel wathionஒன்றுபட்டது கிஂக்டம்மேட் ஹான்காக்ஐரோப்பிய மருந்துகள் அதிகாரம்பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட்